Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00040651
Status:
TERMINATED
Last Update Posted:
2007-12-28
First Post:
2002-07-05
Brief Title:
Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Organization:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Organization Data
Organization:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Class:
NIH
Study ID:
N01 AR92239
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genzyme a Sanofi Company | INDUSTRY |
| University of Pittsburgh | OTHER |
| Amgen | INDUSTRY |